Premium
Regression of Kaposi's sarcoma after intravenous immunoglobulin treatment for polymyositis
Author(s) -
Carmeli Yehuda,
Mevorach Dror,
Kaminski Naftali,
Raz Eyal
Publication year - 1994
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(19940601)73:11<2859::aid-cncr2820731132>3.0.co;2-p
Subject(s) - polymyositis , medicine , sarcoma , antibody , dermatomyositis , intravenous immunoglobulins , kaposi's sarcoma , dermatology , immunology , pathology , human herpesvirus
The authors report on the case of a patient with polymy‐ositis who was given immunosuppressive therapy and then developed Kaposi's sarcoma. Subsequently, the polymyositis was treated with high dose intravenous immunoglobulin, and the Kaposi's sarcoma regressed abruptly. The association between these two diseases and the beneficial effect of intravenous immunoglobulin on Kaposi's sarcoma are discussed. Cancer 1994; 73:2859–61.